{
    "type": "ETF",
    "ucits": true,
    "fund_name": "UBS MSCI Canada UCITS ETF",
    "investment_objective": "Passive replication of MSCI Canada Index (Net Return) via direct investments and/or derivatives for efficiency",
    "primary_asset_class": "Equity",
    "geographic_focus": "Canada",
    "replication_method": "physical",
    "swaps": true,
    "derivatives": false,
    "leverage": false,
    "inverse": false,
    "complex_factors": "Use of OTC derivatives (swaps) for index exposure efficiency and counterparty risk",
    "classification": "complex",
    "supporting_data": "The ETF primarily uses physical replication (full replication of MSCI Canada Index) but also employs derivatives, specifically OTC swaps, to gain exposure where direct replication is impractical or to improve efficiency. The KIID and PRIIPs KID explicitly mention the use of OTC derivatives and associated counterparty risk mitigated by collateral policies. The fund invests predominantly in equities but may hold structured notes and other eligible assets. There is no leverage or inverse exposure. The risk profile is medium to high (risk category 5 in KIID, 4 in PRIIPs KID), reflecting equity volatility and derivative usage. The PRIIPs KID states the product is 'not simple and may be difficult to understand,' indicating complexity under MiFID II. The monthly factsheet confirms physical replication as primary but acknowledges derivative use for efficiency. No capital protection or structured contingent features are present. Costs are straightforward with no performance fees but include derivative trading costs and securities lending. The presence of OTC swaps and counterparty risk exposure, even if mitigated, triggers the MiFID II complexity classification. Although derivatives are used for efficiency rather than inherent leverage or speculative purposes, the swap usage and counterparty risk require classification as complex under MiFID II rules.",
    "risk_level_assessment": "The fund's risk profile is medium to high due to equity market exposure and derivative counterparty risk. The KIID risk category is 5-6, and PRIIPs KID rates it as 4 out of 7. This aligns with the complexity classification, as the use of OTC derivatives and counterparty risk increases the difficulty for retail investors to fully understand the product's risk profile."
}